Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortAnti-leprosy and anti-TB drug that darkens the skin.Old antibiotic for leprosy, dermatitis herpetiformis and PCP prophylaxis.
Body systemAntibioticsAntibiotics
Drug classAntileprosy medicinesAntileprosy medicines
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesLeprosy (multibacillary), Drug-resistant tuberculosis, Mycobacterium avium complexLeprosy, Dermatitis herpetiformis, Pneumocystis pneumonia prevention, Some blistering skin diseases
How it worksKills leprosy bacteria and calms leprosy reactions.Kills leprosy bacteria and calms certain skin inflammation.
Starts workingWeeks to monthsWeeks
Half-lifeAbout 70 days20–30 hours
Typical adult dose50 mg a day with 300 mg once a month in multibacillary leprosy (WHO regimen).100 mg once a day for leprosy.
FormsCapsuleTablet
Common side effectsSkin and body fluid discolouration, Dry skin, Abdominal pain, NauseaSkin rash, Headache, Nausea, Blue tinge to lips (methaemoglobinaemia)
Serious side effectsSevere abdominal pain with crystal deposits, QT prolongation, Depression from skin colour changeHaemolytic anaemia, Methaemoglobinaemia, DRESS syndrome (dapsone hypersensitivity), Nerve damage, Agranulocytosis
Don't take ifAllergy to clofazimine; Severe abdominal pain or bowel obstruction (caution)G6PD deficiency (risk of severe haemolysis); Severe anaemia; Allergy to sulfonamides (cross-reaction possible)
AlcoholUsually no problem in moderation. No specific interaction.Best to limit. Alcohol may add to liver stress.
PregnancyUsually avoidedCrosses the placenta; discoloured newborn skin occurs; use only if essential.Use with cautionUsed in pregnancy for leprosy; folic acid supplements advised.
BreastfeedingUsually avoidedPasses into milk; the baby's skin may darken.Use with cautionPasses into milk; watch for haemolysis in the baby.
In use since——
Brand namesUnited States: Lamprene (special access)United Kingdom: Lamprene (special import)India: Lamprene, Clofazimine (programme supply)United States: Dapsone (generic)United Kingdom: Dapsone (generic)India: Dapsone (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H1United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeJ04BA01J04BA02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker